Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
57.24
+0.27 (+0.47%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
44
45
Next >
Cramer Shrugs Off Stock With Over 10% Yield: 'I Don't Want That Dividend, I Need Growth'
September 28, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Solaris Oilfield Infrastructure, Inc.
Via
Benzinga
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
September 28, 2023
Health insurers UnitedHealth, Humana, and Elevance pay steady dividends, offering stability even as the industry faces headwinds regarding Medicaid coverage.
Via
MarketBeat
Looking At CVS Health's Recent Unusual Options Activity
September 27, 2023
Via
Benzinga
Global Consulting Firm McKinsey To Pay $230M In Opioid Lawsuit Settlements With US Local Governments
September 27, 2023
Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numerous U.S.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Tuesday's Market Minute: Previewing Costco (COST) Earnings
September 26, 2023
Costco (NASDAQ: COST) reports its fourth quarter of 2023 after the bell today. Zacks expects the company to report EPS of $4.72 on revenue of $78.56 billion. The stock has had a strong year thus far,...
Via
Benzinga
Looking Into CVS Health's Recent Short Interest
September 20, 2023
Via
Benzinga
Expert Ratings for CVS Health
September 19, 2023
Via
Benzinga
CVS Health Corp. (NYSE: CVS) Highlighted for Surprising Price Action
September 19, 2023
Via
Investor Brand Network
3 Best Stocks to Buy in September and Hold Forever
September 24, 2023
Healthcare blue chip stocks with proven track records can be excellent long-term investments.
Via
The Motley Fool
CVS Health vs. Walgreens Boots Alliance: Which Is the Better Dividend Stock to Own?
September 21, 2023
Should you go with the high yield or the more conservative, lower payout?
Via
The Motley Fool
Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
September 20, 2023
As the U.S.
Via
Benzinga
Exposures
COVID-19
CVS Health Gains Momentum: Analyst Points To Potential 4-Star Medicare Rating
September 19, 2023
Shares of CVS Health Corp (NYSE: CVS) were trading higher on Tuesday, after attracting short interest earlier in the month.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
September 19, 2023
Via
Benzinga
CVS Health Unusual Options Activity For September 19
September 19, 2023
Via
Benzinga
A Look Into CVS Health Inc's Price Over Earnings
September 14, 2023
Via
Benzinga
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
September 19, 2023
Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37...
Via
Benzinga
2 Beaten-Down Dividend Growth Stocks That Look Like Bargains Now
September 19, 2023
Buying these dividend growers on the dips could lead to huge passive income streams by the time you're ready to retire.
Via
The Motley Fool
3 Stocks That Could Be Kicked Out of the Dow -- and the Companies That May Replace Them
September 19, 2023
Three time-tested yet poor-performing Dow components are at risk of being removed from the index.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Stagflationary Moves In Bonds And Oil Opens Golden Opportunity
September 18, 2023
Is there anything better than stagflationary pressures on gold prices? A weaker dollar and falling interest rates create a sweet spot for gold.
Via
Talk Markets
2 Top Stocks to Buy Near Their 52-Week Lows
September 14, 2023
They are down but not out.
Via
The Motley Fool
Betting With the ‘Big Short’: 3 Michael Burry Stocks to Bank On
September 15, 2023
Burry's insight and strategic thinking led him to invest in three seemingly disparate industries.
Via
InvestorPlace
3 Strong Sell Stocks for September 2023
September 15, 2023
These 3 stocks to avoid aren't offering much right now – except uncertainty and massive risk of potential losses.
Via
InvestorPlace
3 S&P 500 Stocks to Sell Before a Crash
September 13, 2023
Here's a list of S&P 500 stocks to sell. Each has a unique reason behind its bearish thesis, prompting investors to take action.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD
September 13, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now
Via
Benzinga
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
September 13, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This?
September 12, 2023
Health insurers dramatically mark up prices of generics and pharmacies are in on the scheme.
Via
Talk Markets
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...
Via
Benzinga
Exposures
Product Safety
CVS, Walgreens Boots Among Firms Receiving Warning Letter Against Selling Unapproved Eye Products
September 12, 2023
The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating fed
Via
Benzinga
Exposures
Product Safety
It's a Good Time To Buy High-Yield Dogs of the Dividend Kings
September 12, 2023
These Dividend Kings have been hammered for the last year but now offer value and high yield with a chance for a significant share price rebound.
Via
MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
44
45
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.